Compare StocksABBV vs FAST

AbbVie Inc. (ABBV) vs Fastenal Company (FAST): Which Is the Better Buy in 2026?

As of 2026-06-19, ABBV is overvalued at $216, with a DCF intrinsic value of $160 and a margin of safety of -35%. FAST is overvalued at $46, with an intrinsic value of $27 and a margin of safety of -67%. Of the two, ABBV has the wider margin of safety.

ABBV
AbbVie Inc.
$216.49
VS
FAST
Fastenal Company
$45.89

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
FAST
  • Fastenal Company has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Fastenal Company scores 94/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Free cash flow has grown at a 11.0% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • FCF yield of 5.4% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 105.6x is 69% above the historical average of 62.3x — the stock trades at a premium to its own history.
FAST
  • FCF yield of 1.7% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • Trailing P/E of 40.6x is 26% above the historical average of 32.3x — the stock trades at a premium to its own history.
  • PEG ratio of 3.32 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.

Key Valuation Metrics

Learn more →
ABBV
FAST
Valuation
$20.81B
Free Cash Flow
$903.86M
5.44%
FCF Yield
1.72%
105.60
Trailing P/E
40.61
13.32
Forward P/E
33.48
Quality & Moat
21.89%
ROIC
30.57%
N/A
ROE
33.84%
72.03%
Gross Margin
44.89%
0.61
PEG Ratio
3.32
Balance Sheet Safety
N/A
Net Debt / Equity
0.03
N/A
Interest Coverage
N/A
2.12
Net Debt / EBITDA
0.07
3.11%
Dividend Yield
2.01%
ABBV: 6Ties: 1FAST: 3
ABBVFAST

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

FAST

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
FAST
$29.34
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$649.7M
Δ Market Cap
+$19.06B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
35.3% Overvalued
Price is 35.3% above estimated fair value
Current Price: $216.49
Fair Value: $160.05
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
FAST
67.0% Overvalued
Price is 67.0% above estimated fair value
Current Price: $45.89
Fair Value: $27.47
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

What growth rate is the market pricing in at $216?

+17.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.7%

The market implies +17.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.7%, reflecting heavy growth investment.

FAST

What growth rate is the market pricing in at $46?

+17.8%
Market-Implied Owner Earnings Growth
Standard FCF implies +22.4%

The market implies +17.8% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +22.4%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
FAST
94/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
FAST
-2.40
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,106
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
FAST
Insiders 0.1%Institutions 88.2%Retail & Other 11.8%
No. of Institutional Holders1,901
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
FAST
0
Buys (3M)
6
Buys (12M)
Total value (12M): $244,636
NIELSEN SARAH N
Director
$39,600
@ $39.60 · 2025-11-19
JOHNSON DANIEL L.
Director
$40,440
@ $40.44 · 2025-11-17
HSU HSENGHUNG SAM
Director
$40,750
@ $40.75 · 2025-11-13
HSU HSENGHUNG SAM
Director
$40,580
@ $40.58 · 2025-11-13
EASTMAN STEPHEN L
Director
$40,816
@ $40.82 · 2025-11-12
HSU HSENGHUNG SAM
Director
$42,450
@ $42.45 · 2025-10-16
MILLER CHARLES S
Officer
$3,069
@ $76.72 · 2025-04-14
MILLER CHARLES S
Officer
$3,101
@ $77.53 · 2025-04-14
LEWIS HOLDEN
Chief Financial Officer
$15,538
@ $71.94 · 2024-11-21
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID R.
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
GONZALEZ RICHARD A
Officer and Director
$49.50M
@ $175.00 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
FAST
0
Sells (3M)
10
Sells (12M)
Total value (12M): $18.25M
WISECUP REYNE KAY
Director
$1.75M
@ $47.34 · 2026-03-05
SATTERLEE SCOTT ALAN
Director
$705,454
@ $44.19 · 2026-01-23
DRAZKOWSKI WILLIAM JOSEPH
Officer
$333,012
@ $48.67 · 2025-08-15
FLORNESS DANIEL LARS
Chief Executive Officer
$4.10M
@ $48.44 · 2025-08-12
FLORNESS DANIEL LARS
Chief Executive Officer
$4.10M
@ $48.44 · 2025-08-12
WATTS JEFFERY MICHAEL
President
$2.34M
@ $48.05 · 2025-08-08
SODERBERG JOHN LEWIS
Officer
$1.66M
@ $48.03 · 2025-08-08
SODERBERG JOHN LEWIS
Officer
$1.66M
@ $48.03 · 2025-08-08
BROERSMA ANTHONY PAUL
Officer
$650,931
@ $47.93 · 2025-07-24
LISOWSKI SHERYL ANN
Chief Financial Officer
$951,832
@ $45.21 · 2025-07-17
PAPENFUSS DONNALEE KATHLEEN
Officer
$121,983
@ $41.27 · 2025-06-05
SODERBERG JOHN LEWIS
Officer
$1.35M
@ $82.45 · 2025-05-16
SATTERLEE SCOTT ALAN
Director
$768,868
@ $79.51 · 2025-05-06
BROERSMA ANTHONY PAUL
Officer
$452,060
@ $81.19 · 2025-04-25
FLORNESS DANIEL LARS
Chief Executive Officer
$4.11M
@ $82.12 · 2025-04-24
DRAZKOWSKI WILLIAM JOSEPH
Officer
$1.22M
@ $81.31 · 2025-04-14
LEWIS HOLDEN
Chief Financial Officer
$5.15M
@ $74.97 · 2025-03-14
JANSEN JAMES C
Officer
$1.63M
@ $83.07 · 2024-11-22
MILLER CHARLES S
Officer
$1.97M
@ $83.92 · 2024-11-13
JOHNSON DANIEL L.
Director
$706,396
@ $83.36 · 2024-11-13
FLORNESS DANIEL LARS
Chief Executive Officer
$2.69M
@ $84.50 · 2024-11-11
LUNDQUIST NICHOLAS J
Director
$705,695
@ $83.14 · 2024-11-08
PAPENFUSS DONNALEE KATHLEEN
Officer
$374,470
@ $83.92 · 2024-11-08
LISOWSKI SHERYL ANN
Officer and Treasurer
$501,205
@ $83.53 · 2024-11-08
LEWIS HOLDEN
Chief Financial Officer
$3.41M
@ $83.12 · 2024-11-07
DRAZKOWSKI WILLIAM JOSEPH
Officer
$1.42M
@ $82.28 · 2024-11-06
SODERBERG JOHN LEWIS
Officer
$1.59M
@ $82.95 · 2024-11-06
HEISE RITA J
Director
$845,692
@ $77.67 · 2024-10-30
DRAZKOWSKI WILLIAM JOSEPH
Officer
$1.27M
@ $77.65 · 2024-10-16
BROERSMA ANTHONY PAUL
Officer
$52,945
@ $77.86 · 2024-10-16
WISECUP REYNE KAY
Director
$1.71M
@ $78.55 · 2024-10-16
LUNDQUIST NICHOLAS J
Director
$1.74M
@ $77.15 · 2024-10-15
LISOWSKI SHERYL ANN
Officer and Treasurer
$1.03M
@ $76.19 · 2024-10-14
LEWIS HOLDEN
Chief Financial Officer
$2.30M
@ $76.52 · 2024-10-14
FLORNESS DANIEL LARS
Chief Executive Officer
$3.48M
@ $69.68 · 2024-09-12
FLORNESS DANIEL LARS
Chief Executive Officer
$3.12M
@ $68.14 · 2024-08-21
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
FAST
FearGreed
😐Neutral(59/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
FAST
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (59)
View ABBV Full AnalysisView FAST Full Analysis

Frequently Asked Questions: ABBV vs FAST

Is AbbVie Inc. or Fastenal Company more undervalued in 2026?

Based on our discounted cash flow model, ABBV trades at a -35.3% margin of safety (intrinsic value $160 vs. price $216), compared to FAST's -67.0% margin of safety (intrinsic $27 vs. $46).

Which stock has a wider economic moat, AbbVie Inc. or Fastenal Company?

FAST scores 94/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. FAST scores 29.4 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, AbbVie Inc. or Fastenal Company?

AbbVie Inc. (ABBV) generates a 5.4% free cash flow yield, compared to Fastenal Company's 1.7%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, AbbVie Inc. or Fastenal Company?

FAST earns 30.6% ROIC versus ABBV's 21.9%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Fastenal Company's?

ABBV's dividend earns a safety score of 39/100 (Unsafe), compared to FAST's 28/100 (Unsafe). ABBV has raised its dividend for 3 consecutive years.

ABBV vs FAST: Which Is the Better Buy in 2026? | SafetyMargin.io